Adjuvants in micro- to nanoscale: current state and future direction

Area of Science:

• Vaccinology
• Nanotechnology
• Immunology

Background:

• Adjuvants have been integral to vaccines for over 70 years, enhancing immune responses.
• Recent advancements involve combining nanotechnology with immunomodulatory molecules to create novel adjuvant systems.
• These systems offer biocompatibility, immunogenicity, and increased antigen-carrying capacity.

Purpose of the Study:

• To review advancements in adjuvant systems formulations and synthesis.
• To highlight the role of adjuvants in combating global health threats like malaria, hepatitis C, influenza, and HIV.
• To discuss adjuvant-antigen interactions and mechanisms of action for next-generation vaccines.

Main Methods:

• Review of scientific literature on adjuvant systems, nanotechnology, and vaccinology.
• Analysis of synthesis routes for nanoadjuvant formulations.
• Exploration of adjuvant-antigen interactions with cellular receptors.

Main Results:

• Adjuvant systems demonstrate improved antigen delivery and enhanced immune responses.
• Nanotechnology-based adjuvants show promise in addressing major global health challenges.
• Understanding physicochemical factors is key to developing effective nanoadjuvants.

Conclusions:

• Advanced adjuvant systems are crucial for developing next-generation vaccines.
• Nanoadjuvants offer a pathway to more effective, less reactogenic, and multifunctional vaccines.
• Further research into nanoadjuvant-antigen interactions will optimize vaccine design.